[go: up one dir, main page]

FI942188L - Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseksi - Google Patents

Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseksi Download PDF

Info

Publication number
FI942188L
FI942188L FI942188A FI942188A FI942188L FI 942188 L FI942188 L FI 942188L FI 942188 A FI942188 A FI 942188A FI 942188 A FI942188 A FI 942188A FI 942188 L FI942188 L FI 942188L
Authority
FI
Finland
Prior art keywords
antitumor activity
triazine derivatives
enhanced antitumor
enhanced
triazine
Prior art date
Application number
FI942188A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942188A0 (fi
FI942188A7 (fi
Inventor
Jotham Wadsworth Coe
Anton Franz J Fliri
Takushi Kaneko
Eric Robert Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI942188A0 publication Critical patent/FI942188A0/fi
Publication of FI942188L publication Critical patent/FI942188L/fi
Publication of FI942188A7 publication Critical patent/FI942188A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI942188A 1991-11-12 1992-09-16 Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseks i FI942188A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79078991A 1991-11-12 1991-11-12
PCT/US1992/007656 WO1993010116A1 (en) 1991-11-12 1992-09-16 Triazine derivatives for enhancing antitumor activity

Publications (3)

Publication Number Publication Date
FI942188A0 FI942188A0 (fi) 1994-05-11
FI942188L true FI942188L (fi) 1994-05-11
FI942188A7 FI942188A7 (fi) 1994-05-11

Family

ID=25151750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942188A FI942188A7 (fi) 1991-11-12 1992-09-16 Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseks i

Country Status (14)

Country Link
US (1) US5536722A (zh)
EP (1) EP0613477A1 (zh)
JP (1) JPH07506084A (zh)
AU (1) AU2599992A (zh)
CA (1) CA2123402A1 (zh)
FI (1) FI942188A7 (zh)
HU (1) HUT69722A (zh)
IL (1) IL103655A0 (zh)
MX (1) MX9206468A (zh)
NO (1) NO941785L (zh)
PT (1) PT101046A (zh)
TW (1) TW208004B (zh)
WO (1) WO1993010116A1 (zh)
ZA (1) ZA928683B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
JP2002509140A (ja) * 1998-01-13 2002-03-26 アナディーズ・ファーマスーティカルズ，インコーポレイテッド トリアジン抗ウイルス化合物
US6335339B1 (en) * 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
GB2336839A (en) * 1998-04-30 1999-11-03 Sharp Kk Triazine Compounds And Their Use In Electrolumiescent, Electronic and Liquid Crystal Devices
JP2003524595A (ja) 1998-07-08 2003-08-19 モナシュ ユニバーシティ 薬 剤
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
DE60034783T2 (de) * 1999-04-22 2008-01-31 H. Lundbeck A/S, Valby Selektive npy(y5)-antagonisten
US6340683B1 (en) * 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6262053B1 (en) * 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7273880B2 (en) * 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7045247B1 (en) * 2000-08-24 2006-05-16 The Gillette Company Battery cathode
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP2046763A2 (en) * 2006-07-31 2009-04-15 Praecis Pharmaceuticals Incorporated Aurora kinase inhibitors from an encoded small molecule library
ES2621932T3 (es) 2010-10-27 2017-07-05 The Walter And Eliza Hall Institute Of Medical Research Agentes antineoplásicos novedosos
KR101472083B1 (ko) * 2012-10-22 2014-12-16 광주과학기술원 ＥＮＯｂｌｏｃｋ을 유효성분으로 포함하는 암 예방 또는 치료용 약제학적 조성물
JP2019064976A (ja) * 2017-10-03 2019-04-25 国立大学法人 熊本大学 抗がん剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
DE68920798T2 (de) * 1988-08-19 1995-05-18 Warner Lambert Co Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren.
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
HUT64533A (en) * 1990-11-06 1994-01-28 Pfizer Method for producing quinazoline derivatives for improving anti-tumoric activity and preparations containing said compounds
FR2673627B1 (fr) * 1991-03-07 1993-05-07 Adir Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
CA2123402A1 (en) 1993-05-27
NO941785D0 (no) 1994-05-11
ZA928683B (en) 1994-05-11
JPH07506084A (ja) 1995-07-06
EP0613477A1 (en) 1994-09-07
US5536722A (en) 1996-07-16
FI942188A0 (fi) 1994-05-11
AU2599992A (en) 1993-06-15
WO1993010116A1 (en) 1993-05-27
MX9206468A (es) 1993-05-01
NO941785L (no) 1994-05-11
TW208004B (zh) 1993-06-21
PT101046A (pt) 1994-02-28
HU9401385D0 (en) 1994-08-29
FI942188A7 (fi) 1994-05-11
IL103655A0 (en) 1993-04-04
HUT69722A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
FI942188L (fi) Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseksi
FI932032A7 (fi) Kinatsoliinin johdannaisia kasvaimen vastaisen aktiivisuuden lisäämise ksi
FI933656A7 (fi) 2,4-diaminokinatsoliinijohdannaiset, jotka tehostavat kasvaintenvastai sta aktiivisuutta
DE69208877D1 (de) Chinuclidinderivate
FI924160A7 (fi) Benzanilidderivat
FI935726A7 (fi) Atsanorbornaanijohdannaisia
FI924159L (fi) Benzanilidderivat
NO922182L (no) Krystallinske oksatiolan-derivater
DE59208415D1 (de) 3-Hydroxy-4-aryl-5-oxo-pyrazolin Derivate
FI942766A7 (fi) 20-metyylisubstituoituja D-vitamiinijohdannaisia
FI921262L (fi) 4-aryltiazol- eller 4-arylimidazolderivat
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
LV11176A (lv) Uracila atvasinajumi
FI940167L (fi) Puriinijohdannaisia
FI935243L (fi) Pyridonkarboxylsyraderivat
FI953127A0 (fi) Puriinijohdannaisia
FI934565A7 (fi) Pyrimidiinijohdannaisia kasvaimenvastaisen vaikutuksen lisäämiseksi
FI920394A7 (fi) 3-kinuklidiinijohdannaiset
MX9206710A (es) Derivados de piridinol
FI924145L (fi) 3-cykloalkylprop-2-enamidderivat
FI942070A7 (fi) Nitroksialkyyliamidijohdannaiset
FI935293A7 (fi) Propensyraderivat
FI933346A7 (fi) Aminoalkylpyrrolidinyltiokarbapenemderivat
FI912486A7 (fi) 6-substituoituja purinyylipiperatsiinijohdannaisia

Legal Events

Date Code Title Description
FD Application lapsed